Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

SEARCH GUIDE  Download Search Tip PDF File

  • articleNo Access

    Company News

      Acrux in Licensing Agreement for Skin Permeation Platform Technology.

      Agenix to Begin Human Trials for Blood Clot Imaging Project.

      Cancer Vac Successful in Human Trials of Cancer Therapy.

      Terumo to Expand Production Scale in China.

      Ranbaxy in Licensing Agreement for Brain Drug.

      Wockhardt Plans to Expand into US, Europe.

      Zydus Vaccicare to Launch Four Vaccines.

      Tanabe Seiyaku to Develop Small Molecule LFA-1 Antagonists with Novartis.

      Neurogenetics Extends Agreement with Eisai.

      Insect Biotech.

      Boviquest Discovers Cow Milk Production Gene.

      MerLion Pharma Secures US$13.5 Million in Funds.

      CordLife Launches Business Partnership Program.

      Lytone Announces New Uric Acid Control Product.

    • articleNo Access

      Industry Watch

        CyGenics and MCRI Collaborate in Stem Cell Expansion Trials.

        Bionomics Collaborates with Louisiana State University in Cancer Gene Therapy.

        Concerns over Impact of FTA on Pharma Industry.

        Antisense Therapeutics' MS Drug Enters Phase 2 Clinical Trials.

        Cancer Vac Commences Phase II Trial for Ovarian Cancer Treatment.

        Regenera Receives Human Ethics Approval for Visagen Phase III Trial.

        Relenza Dispute between Biota & GSK.

        Rockeby Biomed Test SysCan3 on Newborns in US.

        AstraZeneca Outlines Plan for Expansion of India-based Operations.

        Ranbaxy Seeking New CRO for Generic AIDS Drugs.

        Indian Drug Exports Likely to be Affected by New US Initiatives.

        Acyte and Serono Working on Cell Expression Technology.

        Takeda Withdraws from Five Joint Ventures.

        Kyowa and AnalytiCon Succeeded on Molecule Search.

        Lion Takes On Chugai's OTC Drugs Business.

        Kyorin and Merck Collaborate in Antibiotics Research.

        Fujisawa's New Formulation Facilities Completed.

        CordLife Secured US Defense Contract.